In Vitro and In Vivo Study of Poly(ethylene glycol) Conjugated Ibuprofen to Extend the Duration of Action
2011

Study of PEG-Ibuprofen for Longer Pain Relief

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Nayak Anjali, Jain Anurekha

Primary Institution: B. R. Nahata College of Pharmacy

Hypothesis

Can polyethylene glycol conjugated ibuprofen provide a prolonged release and enhanced therapeutic effect compared to standard ibuprofen?

Conclusion

The PEG-Ibu conjugates demonstrated extended analgesic and anti-inflammatory effects compared to ibuprofen alone.

Supporting Evidence

  • PEG-Ibu conjugates showed increased solubility compared to ibuprofen.
  • The hydrolysis rate of PEG4000-Ibu was slower than PEG600-Ibu.
  • Both conjugates provided significant analgesic effects in animal models.

Takeaway

This study shows that a special version of ibuprofen mixed with a polymer can help it work longer and better for pain relief.

Methodology

The study involved synthesizing PEG-Ibu conjugates, characterizing them, and testing their solubility, hydrolysis, and biological effects in animal models.

Potential Biases

Potential bias in animal selection and treatment administration could affect the results.

Limitations

The study was conducted in vitro and in vivo on a limited number of animal models, which may not fully represent human responses.

Participant Demographics

Swiss albino mice and Wistar rats were used for testing.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3797/scipharm.0911-07

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication